FAIM
LH icon

Financial Advocates Investment Management’s Labcorp LH Stock Holding History

Financial Advocates Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,891
Closed -$909K – 819
2022
Q3 		$909K Buy
+5,891
New +$1.21M 0.08% 273

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $3.05B AUM 42.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Advocates Investment Management's LH Position: Q4 2022 in Review

Financial Advocates Investment Management sold out of Labcorp (LH) in Q4 2022, closing a stake of 5,891 shares — an estimated $909K sold.

Financial Advocates Investment Management first reported a position in LH in Q3 2022 and held it in 1 quarter. The position peaked at $909K in Q3 2022. 971 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Financial Advocates Investment Management reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 5,891 Labcorp shares in Q4 2022, an estimated $909K.
  • Financial Advocates Investment Management first reported a position in Labcorp in Q3 2022 and held it in 1 quarter.
  • Financial Advocates Investment Management's Labcorp position peaked at $909K in Q3 2022.
  • 971 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Financial Advocates Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.